Open original FDA record ↗Recall record
- FDA identifier
- Z-0124-2020
- Company in FDA record
- Integra LifeSciences Corp.
- FDA record creation date
- Oct 12, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is a potential for a progressive decline in observed ICP readings of the monitor during use.
Source facts
- Action
- On 9/12/19, the customers were notified by a visit from the Sales Representative who delivered a notification letter at that time. The letter, URGENT: VOLUNTARY MEDICAL DEVICE RECALL, dated 9/12/19, included the following instructions: 1. If you have a CereLink ICP monitor, Model #826820, discontinue using the product as soon as clinically possible and remove the product from service. 2. Your sales representative will facilitate the return of your monitor. 3. Complete the information on the Acknowledgement Form attached to this letter and either provide it to your sales representative or email or fax as indicated on the form. Keep a copy of the form for your records. Should you have any questions regarding these instructions, please contact Customer Service Monday to Friday 8:00 AM 8:00 PM EST USA: 1-800-654-2873: email: custsvcnj@integralife.com Outside USA: 781-565-1401
- Initiated
- 2019-09-12
- Root cause
- Under Investigation by firm
- Distribution
- The products were distributed to the following US states: CA, CO, CT, FL, IN, NY, OK, PA, TX, WI, and WV. The products were distributed to the following foreign countries: Australia, Belgium.
- Recall number
- Z-0124-2020
- Recall status
- Open, Classified
- CDRH record ID
- 176448
- FDA record created
- 2019-10-12
- Recall event number
- 83831